A KHDC3L mutation resulting in recurrent hydatidiform mole causes genome-wide DNA methylation loss in oocytes and persistent imprinting defects post-fertilisation

被引:48
|
作者
Demond, Hannah [1 ]
Anvar, Zahra [2 ,3 ,4 ]
Jahromi, Bahia Namavar [2 ,3 ]
Sparago, Angela [5 ]
Verma, Ankit [4 ,5 ]
Davari, Maryam [3 ,6 ]
Calzari, Luciano [7 ]
Russo, Silvia [7 ]
Jahromi, Mojgan Akbarzadeh [8 ]
Monk, David [9 ]
Andrews, Simon [10 ]
Riccio, Andrea [4 ,5 ]
Kelsey, Gavin [1 ,11 ]
机构
[1] Babraham Inst, Epigenet Programme, Cambridge, England
[2] Shiraz Univ Med Sci, Infertil Res Ctr, Shiraz, Iran
[3] Shiraz Univ Med Sci, Sch Med, Dept Obstet & Gynecol, Shiraz, Iran
[4] CNR, Inst Genet & Biophys Adrian Buzzati Traverso, Naples, Italy
[5] Univ Campania Luigi Vanvitelli, Caserta, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Caserta, Italy
[6] Ghadir Mother & Child Hosp Shiraz, IVF Sect, Shiraz, Iran
[7] Ist Auxol Italiano, Ctr Ric & Tecnol Biomed IRCCS, Med Cytogenet & Mol Genet Lab, Milan, Italy
[8] Shiraz Univ Med Sci, Dept Pathol, Shiraz, Iran
[9] Bellvitge Biomed Res Inst IDIBELL, Imprinting & Canc Grp, Barcelona, Spain
[10] Babraham Inst, Bioinformat Grp, Cambridge, England
[11] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
Epigenetics; DNA methylation; Genomic imprinting; Single-cell analysis; Oocytes; Embryos; EFFECT GENE; ESTABLISHMENT; TRANSCRIPTION; LANDSCAPE; FOLLICLES; MULTIPLE; DNMT3L; ZFP57; LINKS; MARKS;
D O I
10.1186/s13073-019-0694-y
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Maternal effect mutations in the components of the subcortical maternal complex (SCMC) of the human oocyte can cause early embryonic failure, gestational abnormalities and recurrent pregnancy loss. Enigmatically, they are also associated with DNA methylation abnormalities at imprinted genes in conceptuses: in the devastating gestational abnormality biparental complete hydatidiform mole (BiCHM) or in multi-locus imprinting disease (MLID). However, the developmental timing, genomic extent and mechanistic basis of these imprinting defects are unknown. The rarity of these disorders and the possibility that methylation defects originate in oocytes have made these questions very challenging to address. Methods: Single-cell bisulphite sequencing (scBS-seq) was used to assess methylation in oocytes from a patient with BiCHM identified to be homozygous for an inactivating mutation in the human SCMC component KHDC3L. Genomewide methylation analysis of a preimplantation embryo and molar tissue from the same patient was also performed. Results: High-coverage scBS-seq libraries were obtained from five KHDC3L(c.1A>G) oocytes, which revealed a genome-wide deficit of DNA methylation compared with normal human oocytes. Importantly, germline differentially methylated regions (gDMRs) of imprinted genes were affected similarly to other sequence features that normally become methylated in oocytes, indicating no selectivity towards imprinted genes. A range of methylation losses was observed across genomic features, including gDMRs, indicating variable sensitivity to defects in the SCMC. Genome-wide analysis of a pre-implantation embryo and molar tissue from the same patient showed that following fertilisation methylation defects at imprinted genes persist, while most non-imprinted regions of the genome recover near-normal methylation post-implantation. Conclusions: We show for the first time that the integrity of the SCMC is essential for de novo methylation in the female germline. These findings have important implications for understanding the role of the SCMC in DNA methylation and for the origin of imprinting defects, for counselling affected families, and will help inform future therapeutic approaches.
引用
收藏
页数:14
相关论文
共 1 条
  • [1] A KHDC3L mutation resulting in recurrent hydatidiform mole causes genome-wide DNA methylation loss in oocytes and persistent imprinting defects post-fertilisation
    Hannah Demond
    Zahra Anvar
    Bahia Namavar Jahromi
    Angela Sparago
    Ankit Verma
    Maryam Davari
    Luciano Calzari
    Silvia Russo
    Mojgan Akbarzadeh Jahromi
    David Monk
    Simon Andrews
    Andrea Riccio
    Gavin Kelsey
    Genome Medicine, 11